SCHEMBL26920248

SCHEMBL26920248

CC1(C)OB(c2ccc3nn(C(F)F)cc3c2Cl)OC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23208898 0.88 ACACB (0.35) —
SCHEMBL24740796 0.86 JAK2 (0.33) —
SCHEMBL26920838 0.86 LPL (0.31) —
SCHEMBL21631597 0.81 PTPN11 (0.34) —
SCHEMBL26921302 0.80 — —
SCHEMBL21653819 0.78 FFAR1 (0.32) —
SCHEMBL21631662 0.78 PTPN11 (0.35) —
SCHEMBL29993835 0.78 — —
SCHEMBL26921676 0.76 PTPN11 (0.33) —
SCHEMBL23209055 0.74 PTPN11 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109900-A1 AZABICYCLIC SHP2 INHIBITORS PROMIDIS S.R.L. (IT) 2024-04-04 — — US disclosed
EP-4288431-A1 AZABICYCLIC SHP2 INHIBITORS IRBM S.P.A. (IT) 2023-12-13 — — EP disclosed
CN-116323622-A Bicyclic heteroaryl derivatives, preparation method and application thereof 浙江海正药业股份有限公司 2023-06-23 — — CN disclosed
WO-2022237178-A1 BICYCLIC HETEROARYL DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF 浙江海正药业股份有限公司 2022-11-17 — — WO disclosed
WO-2022167682-A1 AZABICYCLIC SHP2 INHIBITORS IRBM S.P.A. (IT) 2022-08-11 — — WO disclosed
Send feedback